Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Trade Tracker: Bill Baruch sells Thermo Fisher, trims Amgen and buys Eli Lilly

Summary by CNBC
Bill Baruch, Blue Line Capital founder and president, joins CNBC’s 'Halftime Report' to detail his latest portfolio moves.

1 Articles

CNBCCNBC
Lean Left

Trade Tracker: Bill Baruch sells Thermo Fisher, trims Amgen and buys Eli Lilly

Bill Baruch, Blue Line Capital founder and president, joins CNBC’s 'Halftime Report' to detail his latest portfolio moves.

·United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

CNBC broke the news in United States on Tuesday, May 5, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Amgen icon

Amgen

Eli Lilly icon

Eli Lilly

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal